Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy

Abstract An elderly Japanese woman developed acute decompensated heart failure caused by persistent atrial fibrillation (AF) and left ventricular systolic dysfunction. Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardiov...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Koji Takahashi, Mina Yamashita, Tomoki Sakaue, Daijiro Enomoto, Shigeki Uemura, Takafumi Okura, Shuntaro Ikeda, Masafumi Takemoto, Yutaka Utsunomiya, Takashi Hyodo
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	amiodarone atrial fibrillation heart failure landiolol long QT syndrome torsade de pointes Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/9ea9a426f4764e658a42aa67af678946
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9ea9a426f4764e658a42aa67af678946
record_format	dspace
spelling	oai:doaj.org-article:9ea9a426f4764e658a42aa67af6789462021-11-12T11:40:14ZSuppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy1542-474X1082-720X10.1111/anec.12842https://doaj.org/article/9ea9a426f4764e658a42aa67af6789462021-11-01T00:00:00Zhttps://doi.org/10.1111/anec.12842https://doaj.org/toc/1082-720Xhttps://doaj.org/toc/1542-474XAbstract An elderly Japanese woman developed acute decompensated heart failure caused by persistent atrial fibrillation (AF) and left ventricular systolic dysfunction. Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of AF, electrocardiograms revealed a prolonged QT interval associated with torsade de pointes (TdP). The amiodarone‐induced TdP disappeared after intravenous administration of landiolol plus magnesium and potassium, without discontinuation of amiodarone or overdrive cardiac pacing, although the prolonged QT interval persisted. To the best of our knowledge, this is the first report that landiolol could be effective for amiodarone‐induced TdP.Koji TakahashiMina YamashitaTomoki SakaueDaijiro EnomotoShigeki UemuraTakafumi OkuraShuntaro IkedaMasafumi TakemotoYutaka UtsunomiyaTakashi HyodoWileyarticleamiodaroneatrial fibrillationheart failurelandiolollong QT syndrometorsade de pointesDiseases of the circulatory (Cardiovascular) systemRC666-701ENAnnals of Noninvasive Electrocardiology, Vol 26, Iss 6, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	amiodarone atrial fibrillation heart failure landiolol long QT syndrome torsade de pointes Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	amiodarone atrial fibrillation heart failure landiolol long QT syndrome torsade de pointes Diseases of the circulatory (Cardiovascular) system RC666-701 Koji Takahashi Mina Yamashita Tomoki Sakaue Daijiro Enomoto Shigeki Uemura Takafumi Okura Shuntaro Ikeda Masafumi Takemoto Yutaka Utsunomiya Takashi Hyodo Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
description	Abstract An elderly Japanese woman developed acute decompensated heart failure caused by persistent atrial fibrillation (AF) and left ventricular systolic dysfunction. Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of AF, electrocardiograms revealed a prolonged QT interval associated with torsade de pointes (TdP). The amiodarone‐induced TdP disappeared after intravenous administration of landiolol plus magnesium and potassium, without discontinuation of amiodarone or overdrive cardiac pacing, although the prolonged QT interval persisted. To the best of our knowledge, this is the first report that landiolol could be effective for amiodarone‐induced TdP.
format	article
author	Koji Takahashi Mina Yamashita Tomoki Sakaue Daijiro Enomoto Shigeki Uemura Takafumi Okura Shuntaro Ikeda Masafumi Takemoto Yutaka Utsunomiya Takashi Hyodo
author_facet	Koji Takahashi Mina Yamashita Tomoki Sakaue Daijiro Enomoto Shigeki Uemura Takafumi Okura Shuntaro Ikeda Masafumi Takemoto Yutaka Utsunomiya Takashi Hyodo
author_sort	Koji Takahashi
title	Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
title_short	Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
title_full	Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
title_fullStr	Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
title_full_unstemmed	Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
title_sort	suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/9ea9a426f4764e658a42aa67af678946
work_keys_str_mv	AT kojitakahashi suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT minayamashita suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT tomokisakaue suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT daijiroenomoto suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT shigekiuemura suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT takafumiokura suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT shuntaroikeda suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT masafumitakemoto suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT yutakautsunomiya suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy AT takashihyodo suppressionofamiodaroneinducedtorsadedepointesbylandiololinapatientwithatrialfibrillationmediatedcardiomyopathy
_version_	1718430634373808128

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy

Ejemplares similares